These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data]. Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma homocysteine and cysteine are associated with endothelial dysfunction across menopausal stages in healthy women. Keller AC; Klawitter J; Hildreth KL; Christians U; Putnam K; Kohrt WM; Reusch JEB; Moreau KL J Appl Physiol (1985); 2019 Jun; 126(6):1533-1540. PubMed ID: 30896357 [TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine and vascular disease in elderly patients with mental illness. Nilsson K; Gustafson L; Hultberg B Clin Chem Lab Med; 2008; 46(11):1556-61. PubMed ID: 18842107 [TBL] [Abstract][Full Text] [Related]
16. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease. Stehouwer CD; Jakobs C Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036 [TBL] [Abstract][Full Text] [Related]
17. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Stanger O; Weger M Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024 [TBL] [Abstract][Full Text] [Related]
18. Vascular biomarkers of cognitive performance in a community-based elderly population: the Dublin Healthy Ageing study. Chin AV; Robinson DJ; O'Connell H; Hamilton F; Bruce I; Coen R; Walsh B; Coakley D; Molloy A; Scott J; Lawlor BA; Cunningham CJ Age Ageing; 2008 Sep; 37(5):559-64. PubMed ID: 18667454 [TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Nilsson K; Gustafson L; Hultberg B Dement Geriatr Cogn Disord; 2006; 22(4):358-66. PubMed ID: 16954692 [TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]